Lyell Immunopharma

URI: https://gptkb.org/entity/Lyell_Immunopharma

GPTKB entity

Predicate	Object
gptkbp:instanceOf	gptkb:biotechnology
gptkbp:CEO	gptkb:Rick_Klausner
gptkbp:collaboratesWith	gptkb:Fred_Hutchinson_Cancer_Research_Center GlaxoSmithKline
gptkbp:focusesOn	gptkb:gene_therapy gptkb:immunotherapy gptkb:cancer
gptkbp:foundedYear	2018
gptkbp:founder	gptkb:Rick_Klausner
gptkbp:headquartersLocation	gptkb:South_San_Francisco,_California,_United_States
gptkbp:industry	gptkb:biotechnology
gptkbp:notableProduct	gptkb:LYL132 gptkb:LYL797 LYL845
gptkbp:publiclyTraded	yes
gptkbp:specializesIn	T-cell therapies
gptkbp:stockExchange	gptkb:NASDAQ
gptkbp:stockSymbol	gptkb:LYEL
gptkbp:website	https://www.lyell.com/
gptkbp:bfsParent	gptkb:Hans_Bishop gptkb:Richard_Klausner
gptkbp:bfsLayer	6
http://www.w3.org/2000/01/rdf-schema#label	Lyell Immunopharma